Healthcare - Biotechnology - NASDAQ - CA
$ 1.7
-6.08 %
$ 90.6 M
Market Cap
-1.68
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
295.74%
EBIT
Estimate
5.34%
Net Income
Estimate
32.34%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Milestone Pharmaceuticals Inc.
MIST has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart MIST
EBIT FORECAST
EBIT Forecast Chart MIST
NET INCOME FORECAST
Net Income Chart MIST